Johnson & Johnson (JNJ) Stock
JNJ Key Statistics
About Johnson & Johnson
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
CEO: Joaquin Duato. Company website
JNJ — Frequently Asked Questions
What is the JNJ stock price today?
Johnson & Johnson (JNJ) trades at $269.99, down 0.09% on the day, as of Sep 20, 2026 13:06 UTC.
What is Johnson & Johnson's market cap?
Johnson & Johnson has a market capitalisation of $650.65B, calculated from the live JNJ share price and shares outstanding.
What is the P/E ratio of JNJ?
JNJ trades at a trailing P/E of 31.29, from earnings per share of $8.63 over the last twelve months.
How much revenue does Johnson & Johnson make?
Johnson & Johnson generated revenue of $97.93B over the trailing twelve months, which puts the stock at 6.64 times sales.
Does JNJ pay a dividend?
Yes. Johnson & Johnson pays a dividend yielding 2.36% on the current share price.
What is the 52-week range for JNJ?
JNJ has traded between $173.33 and $281.07 over the past 52 weeks, and the last price is 3.9% below that high.
Is Johnson & Johnson profitable?
Yes. Johnson & Johnson keeps 21.48% of revenue as net income over the trailing twelve months.
What is the analyst price target for JNJ?
Wall Street analysts rate JNJ Buy, with an average price target of $286.93, 6.3% above the current price.
What sector is Johnson & Johnson in?
Johnson & Johnson is classified under the Healthcare sector and the Drug Manufacturers - General industry, and is domiciled in US.
Who is the CEO of Johnson & Johnson?
Joaquin Duato is the chief executive of Johnson & Johnson, which employs 141,700 people.
Where can I track JNJ in real time?
QFI Terminal shows JNJ with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See JNJ live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open JNJ in Terminal See plans